association

Full identifier: http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association

Assigned to 1 class:

Minted in Nanopublication

 RAZBNExVLj comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RAZBNExVLj...#association This association http://www.w3.org/2000/01/rdf-schema#label has label (this is a literal) "the use of metoclopramide tablets is recommended for adults only therapy should not exceed 12 weeks in duration symptomatic gastroesophageal reflux metoclopramide tablets are indicated as short term 4 to 12 weeks therapy for adults with symptomatic documented gastroesophageal reflux who fail to respond to conventional therapy the principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms if symptoms are confined to particular situations such as following the evening meal use of metoclopramide as single doses prior to the provocative situation should be considered rather than using the drug throughout the day healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12 week trial using doses of 15 mg q i d as there is no documented correlation between symptoms and healing of esophageal lesions patients with documented lesions should be monitored endoscopically diabetic gastroparesis diabetic gastric stasis metoclopramide tablets are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis the usual manifestations of delayed gastric emptying e g nausea vomiting heartburn persistent fullness after meals and anorexia appear to respond to metoclopramide within different time intervals significant relief of nausea occurs early and continues to improve over a three week period relief of vomiting and anorexia may precede the relief of abdominal fullness by one week or more" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAZBNExVLj... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-21T10:07:59.502+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAZBNExVLj... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAZBNExVLj... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAZBNExVLj... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-21T08:07:59.502Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
the use of metoclopramide tablets is recommended for adults only therapy should not exceed 12 weeks in duration symptomatic gastroesophageal reflux metoclopramide tablets are indicated as short term 4 to 12 weeks therapy for adults with symptomatic documented gastroesophageal reflux who fail to respond to conventional therapy the principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms if symptoms are confined to particular situations such as following the evening meal use of metoclopramide as single doses prior to the provocative situation should be considered rather than using the drug throughout the day healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12 week trial using doses of 15 mg q i d as there is no documented correlation between symptoms and healing of esophageal lesions patients with documented lesions should be monitored endoscopically diabetic gastroparesis diabetic gastric stasis metoclopramide tablets are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis the usual manifestations of delayed gastric emptying e g nausea vomiting heartburn persistent fullness after meals and anorexia appear to respond to metoclopramide within different time intervals significant relief of nausea occurs early and continues to improve over a three week period relief of vomiting and anorexia may precede the relief of abdominal fullness by one week or more
Leoni Bücken
2021-06-21T08:07:59.502Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-21T08:07:59.502Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-21T08:07:59.502Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-21T08:07:59.502Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-21T08:07:59.502Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-21T08:07:59.502Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-21T08:07:59.502Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)